Zhou Lihan is the founder of Mirxes. Mirxes has raised $137M in total funding. Latest round: Series D. Based in Singapore, Singapore.
Zhou Lihan is the co-founder of Mirxes, a biotechnology company that became the first from Southeast Asia to list on the Hong Kong Stock Exchange via an IPO in May 2025. He led Mirxes through multiple funding rounds, including US$87 million in Series C in 2021 and US$50 million in Series D, establishing Southeast Asia's largest Industry 4.0 in vitro diagnostic manufacturing facility.
Full founder directory · Investor directory · Company funding database · Fundraising library